Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration

ClinicalTrials.gov ID: NCT00061594

Public ClinicalTrials.gov record NCT00061594. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicenter, Randomized, Double Masked, Active Treatment-Controlled Study of the Efficacy and Safety of rhuFab V2 (Ranibizumab) Compared With Verteporfin (Visudyne) Photodynamic Therapy in Subjects With Predominantly Classic Subfoveal Neovascular Age-Related Macular Degeneration

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase III, multicenter, randomized, double-masked, active treatment-controlled study of intravitreally administered ranibizumab compared with verteporfin (Visudyne) photodynamic therapy (PDT) in treating subfoveal neovascular mascular degeneration.

Study identification

NCT ID
NCT00061594
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Genentech, Inc.
Industry
Enrollment
426 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2003 (Type not available)
Primary completion
Not listed
Completion
Sep 2006 (Actual)
Last update posted
Mar 19, 2014

2003 – 2006

United States locations

U.S. sites
70
U.S. states
26
U.S. cities
63
Facility City State ZIP Site status
Retina Centers, P.C. Tucson Arizona 85704 —
University of Arizona Tucson Arizona 85711 —
Retina-Vitreous Associates Medical Group Beverly Hills California 90211 —
UC Irvine Irvine California 92697 —
Doheny Eye Institute Los Angeles California 90033 —
California Vitreoretinal Research Center Menlo Park California 94025 —
No. California Retina-Vitreous Associates Mountain View California 94040 —
UCSF School of Medicine San Francisco California 94143 —
Danbury Eye Physicians & Surgeons Danbury Connecticut 06810 —
New England Retina Associates Hamden Connecticut 06518 —
Florida Retina Institute Daytona Beach Florida 32114 —
Retina Vitreous Consultants Fort Lauderdale Florida 33334 —
Retina Consultants of Southwest Florida Fort Myers Florida 33901 —
Retina Health Center Fort Myers Florida 33901 —
Retina Associates of South Florida Margate Florida 33063 —
Bascom Palmer Eye Institute Miami Florida 33136 —
Central Florida Retina Orlando Florida 32806 —
Retina Care Specialists Palm Beach Gardens Florida 33410 —
Bascom Palmer Eye Institute Palm Beach Gardens Florida 33418 —
Ophthalmic Consultants Sarasota Florida 34239 —
Southern Vitreoretinal Associates PA Tallahassee Florida 32308 —
University of South Florida Tampa Florida 33612 —
Emory University Atlanta Georgia 30322 —
Medical College of Georgia Augusta Georgia 30912 —
Thomas A. Ciulla, MD, PC Indianapolis Indiana 46280 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Retina Associates PC Annapolis Maryland 21401 —
New England Eye Center Boston Massachusetts 02111 —
Center for Eye Research Boston Massachusetts 02114 —
New England Retina Consultants West Springfield Massachusetts 01089 —
University of Michigan Ann Arbor Michigan 48105 —
Associated Retinal Consultants Grand Rapids Michigan 49546 —
Associated Retinal Consultants, P.C. Royal Oak Michigan 48073 —
Retina Consultants of Michigan Southfield Michigan 48034 —
Retina Associates of St. Louis Florissant Missouri 63031 —
St. Louis University Eye Institute St Louis Missouri 63104 —
Delaware Valley Retina Associates Lawrenceville New Jersey 08648 —
Lions Eye Institute Albany New York 12208 —
Ophthalmic Consultants of Long Island Rockville Centre New York 11570 —
Western Carolina Retinal Associates, PA Asheville North Carolina 28803 —
Southeast Clinical Research Charlotte North Carolina 28210 —
Duke Univ Medical Center/Duke Eye Center Durham North Carolina 22710 —
Retina Associates of Cleveland Beachwood Ohio 44122 —
Flavio Company Cincinnati Ohio 45242 —
Cleveland Clinic Foundation/Cole Eye Institute Cleveland Ohio 44195 —
Midwest Retina Columbus Ohio 43215 —
Retina Vitreous Associates Toledo Ohio 43608 —
Retinal Associates of Oklahoma Oklahoma City Oklahoma 73120 —
Retina & Vitreous Center of So. Oregon Ashland Oregon 97520 —
Pennsylvania Retina Specialists Camp Hill Pennsylvania 17011 —
Wills Eye Hospital Philadelphia Pennsylvania 19107 —
Allegheny General Hospital Pittsburgh Pennsylvania 15212 —
Retina Consultants of Charleston Charleston South Carolina 29414 —
Palmetto Retina Center Columbia South Carolina 29204 —
BH Regional Eye Institute Rapid City South Dakota 57701 —
Southeastern Retina Associates, P.C. Knoxville Tennessee 37909 —
Retina Vitreous Associates Nashville Tennessee 37203 —
Austin Retina Associates Austin Texas 78705 —
Brian Berger, MD P.A. Austin Texas 78705 —
Retina Specialists DeSoto Texas 75115 —
UTMB Galveston Texas 77555 —
Vitreoretinal Consultants Houston Texas 77030 —
Valley Retina Institute, P.A. McAllen Texas 78503 —
Univ of Texas Health Science Center San Antonio Texas 78229 —
Medical Center Ophthalmology San Antonio Texas 78240 —
Rocky Mountain Retina Consultants Salt Lake City Utah 84107 —
John Moran Eye Center/Univ of Utah Salt Lake City Utah 84132 —
Retina Group of Washington Fairfax Virginia 22031 —
Vitreoretinal Associates Seattle Washington 98104 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00061594, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 19, 2014 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00061594 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →